Lightnix

Lightnix Inc. is a Japanese medical device manufacturer established in 2002 with the goal of developing human and environmentally friendly medical products. The company's main product is the 'PINNIX LIGHT,' the world's first lancet needle made from a plant-based, biodegradable resin. This product was developed over a ten-year research period and was commercialized in 2012 after receiving approval from Japan's Ministry of Health, Labour and Welfare.

The design of the lancet needle simulates the shape of a mosquito's proboscis, which allows for a much smaller incision compared to traditional metal needles, resulting in significantly less pain for the patient. Lightnix's products are manufactured entirely in Japan, using only Japanese materials. The business model focuses on the manufacturing and sale of these medical devices. The company also applies its proprietary low-invasive technology to develop other devices, such as those for intradermal vaccine and antibody drug delivery, and for applications in the cosmetics field.

Lightnix was founded in Hyogo on May 9, 2002. Over the years, it has received capital funding from several entities, including the Hyogo Economic Development Center (2003), Minato Capital Co., Ltd. (2006), Nagoya Small and Medium Business Investment & Consultation Co., Ltd. (2008), and a consortium including Universal Materials Incubator Co., LTD, Mitsubishi UFJ Capital Co., and KSP, Inc. (2019). The company established its head office in Tokyo in May 2017 and later relocated it to a new manufacturing factory in Saitama in July 2018. As of December 2024, the CEO is Shosuke Kiba.

Keywords: medical devices, plant-based resin, lancet needle, biodegradable medical, low-invasive technology, mosquito proboscis needle, blood sampling, intradermal vaccine, drug delivery, PINNIX LIGHT, medical equipment manufacturing, Japanese medical technology, sustainable healthcare, less painful injection, bio-plastic medical devices, healthcare solutions, medical consumables, diabetes care